From TokenPost · · 30s
TL;DR: Rhythm Pharmaceuticals Shares Rise 5.4%
Rhythm Pharmaceuticals shares climb 5.4% as Eli Lilly evaluates obesity market acquisition target.
Rhythm Pharmaceuticals shares rose 5.4% at 12:22 p.m. ET on November 17 after Eli Lilly reportedly considered acquiring the company for obesity market expansion. Rhythm Pharmaceuticals shares climb 5.4% as Eli Lilly evaluates obesity market acquisition target. Rhythm Pharmaceuticals shares rose 5.4% at 12:22 p.m. ET on November 17. Eli Lilly reportedly evaluating Rhythm Pharmaceuticals as potential obesity market acquisition target.
- Rhythm Pharmaceuticals Shares
- Eli Lilly Evaluation
- Viking Therapeutics Speculation
Read the story version — the same reporting as a swipeable deck of 3 cards.






